Akynzeo

Active Ingredient(s): Netupitant + Palonosetron Hydrochloride
FDA Approved: * October 10, 2014
Pharm Company: * HELSINN HLTHCARE
Category: Nausea & Vomiting

Palonosetron, sold under the brand name Aloxi, is used for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).[1][3][4] It is a 5-HT3 antagonist.[1][3][4] Palonosetron is administered intravenously,[5] or as a single oral capsule.[6] It has a longer duration of action than other 5-HT3 antagonists. The oral formulation was approved on Aug... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Akynzeo Oral Capsule
NDC: 62856-796
Labeler:
Eisai Inc.
Akynzeo Oral Capsule
NDC: 69639-101
Labeler:
Helsinn Therapeutics (U.s.), Inc.
Akynzeo Intravenous Injection
NDC: 69639-102
Labeler:
Helsinn Therapeutics (U.s.), Inc.
Akynzeo Intravenous Injection
NDC: 69639-105
Labeler:
Helsinn Therapeutics (U.s.), Inc.
Akynzeo Intravenous Injection
NDC: 69639-106
Labeler:
Helsinn Therapeutics (U.s.), Inc.